Highlights
NASDAQ: DCTH       Delcath Systems Inc
Last Price Today's Change   Day's Range   Trading Volume
0.057   -0.023 (28.75%)  0.05 - 0.068  44,744,797

Overview

 
Avg Volume (4 weeks):54,567,274
4 Weeks Range:0.05 - 0.144
4 Weeks Price Volatility (%):
7.45%
52 Weeks Range:0.01 - 3.76
52 Weeks Price Volatility (%):
1.25%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Delcath Systems, Inc. is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company's system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

  Be the first to like this.
 
k6ii Anyone here see this stock?
21/09/2016 10:41


 

4614  2540  813  431 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BAC 25.02-0.14 
 SPY 249.44+0.05 
 AMD 13.30-0.11 
 AAPL 151.89-1.50 
 DCTH 0.057-0.023 
 ESV 5.24+0.02 
 XLF 25.43-0.03 
 VSAR 2.675-18.925 
 GE 24.87+0.12 
 EEM 45.38-0.26 
Partners & Brokers